These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 29871592

  • 1. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
    Marmur J, Beshara S, Eggertsen G, Onelöv L, Albiin N, Danielsson O, Hultcrantz R, Stål P.
    BMC Gastroenterol; 2018 Jun 05; 18(1):78. PubMed ID: 29871592
    [Abstract] [Full Text] [Related]

  • 2. Hepcidin resistance in dysmetabolic iron overload.
    Rametta R, Dongiovanni P, Pelusi S, Francione P, Iuculano F, Borroni V, Fatta E, Castagna A, Girelli D, Fargion S, Valenti L.
    Liver Int; 2016 Oct 05; 36(10):1540-8. PubMed ID: 26998752
    [Abstract] [Full Text] [Related]

  • 3. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S, Alkim H, Alkim C, Koksal AR, Bayram M, Yilmaz Ozguven MB, Tekin Neijmann S.
    J Gastrointestin Liver Dis; 2015 Sep 05; 24(3):293-300. PubMed ID: 26405701
    [Abstract] [Full Text] [Related]

  • 4. Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model.
    Hasebe T, Tanaka H, Sawada K, Nakajima S, Ohtake T, Fujiya M, Kohgo Y.
    J Gastroenterol; 2017 Mar 05; 52(3):341-351. PubMed ID: 27364348
    [Abstract] [Full Text] [Related]

  • 5. Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans.
    Daher R, Kannengiesser C, Houamel D, Lefebvre T, Bardou-Jacquet E, Ducrot N, de Kerguenec C, Jouanolle AM, Robreau AM, Oudin C, Le Gac G, Moulouel B, Loustaud-Ratti V, Bedossa P, Valla D, Gouya L, Beaumont C, Brissot P, Puy H, Karim Z, Tchernitchko D.
    Gastroenterology; 2016 Mar 05; 150(3):672-683.e4. PubMed ID: 26582087
    [Abstract] [Full Text] [Related]

  • 6. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.
    Aigner E, Theurl I, Theurl M, Lederer D, Haufe H, Dietze O, Strasser M, Datz C, Weiss G.
    Am J Clin Nutr; 2008 May 05; 87(5):1374-83. PubMed ID: 18469261
    [Abstract] [Full Text] [Related]

  • 7. Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?
    Rametta R, Fracanzani AL, Fargion S, Dongiovanni P.
    Curr Pharm Des; 2020 May 05; 26(10):1025-1035. PubMed ID: 32003680
    [Abstract] [Full Text] [Related]

  • 8. Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload.
    Barisani D, Pelucchi S, Mariani R, Galimberti S, Trombini P, Fumagalli D, Meneveri R, Nemeth E, Ganz T, Piperno A.
    J Hepatol; 2008 Jul 05; 49(1):123-33. PubMed ID: 18462824
    [Abstract] [Full Text] [Related]

  • 9. Hepcidin expression in iron overload diseases is variably modulated by circulating factors.
    Ravasi G, Pelucchi S, Trombini P, Mariani R, Tomosugi N, Modignani GL, Pozzi M, Nemeth E, Ganz T, Hayashi H, Barisani D, Piperno A.
    PLoS One; 2012 Jul 05; 7(5):e36425. PubMed ID: 22586470
    [Abstract] [Full Text] [Related]

  • 10. Non-invasive methods for iron overload evaluation in dysmetabolic patients.
    Branisso PPF, de Oliveira CPMS, Filho HML, Lima FR, Santos AS, Mancini MC, de Melo ME, Carrilho FJ, Rocha MS, Clark P, Branisso HJP, Cercato C.
    Ann Hepatol; 2022 Jul 05; 27(4):100707. PubMed ID: 35477031
    [Abstract] [Full Text] [Related]

  • 11. Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.
    Lyberopoulou A, Chachami G, Gatselis NK, Kyratzopoulou E, Saitis A, Gabeta S, Eliades P, Paraskeva E, Zachou K, Koukoulis GK, Mamalaki A, Dalekos GN, Simos G.
    PLoS One; 2015 Jul 05; 10(8):e0135486. PubMed ID: 26270641
    [Abstract] [Full Text] [Related]

  • 12. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
    Bardou-Jacquet E, Philip J, Lorho R, Ropert M, Latournerie M, Houssel-Debry P, Guyader D, Loréal O, Boudjema K, Brissot P.
    Hepatology; 2014 Mar 05; 59(3):839-47. PubMed ID: 23775519
    [Abstract] [Full Text] [Related]

  • 13. The Role of Iron and Iron Overload in Chronic Liver Disease.
    Milic S, Mikolasevic I, Orlic L, Devcic E, Starcevic-Cizmarevic N, Stimac D, Kapovic M, Ristic S.
    Med Sci Monit; 2016 Jun 22; 22():2144-51. PubMed ID: 27332079
    [Abstract] [Full Text] [Related]

  • 14. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.
    Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H, Kobayashi Y, Iwasa M, Watanabe S, Adachi Y, Kaito M.
    Mol Med; 2007 Jun 22; 13(1-2):97-104. PubMed ID: 17515961
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iron overload and non-alcoholic fatty liver disease.
    Datz C, Müller E, Aigner E.
    Minerva Endocrinol; 2017 Jun 22; 42(2):173-183. PubMed ID: 27834478
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
    Gutschow P, Schmidt PJ, Han H, Ostland V, Bartnikas TB, Pettiglio MA, Herrera C, Butler JS, Nemeth E, Ganz T, Fleming MD, Westerman M.
    Haematologica; 2015 Feb 22; 100(2):167-77. PubMed ID: 25425686
    [Abstract] [Full Text] [Related]

  • 20. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM, Allam M, Allam A, Attia MH, El Taher S, Eldin MM, Ali A.
    Egypt J Immunol; 2010 Feb 22; 17(2):33-44. PubMed ID: 23082485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.